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Purpose: The purpose of this study was to analyze the efficacy of an Internet-based program 
for depressive symptoms using automated support by information and communication technolo-
gies (ICTs) and human support.
Patients and methods: An Internet-based program was used to teach adaptive ways to cope 
with depressive symptoms and daily problems. A total of 124 participants who were experiencing 
at least one stressful event that caused interference in their lives, many of whom had clinically 
significant depressive symptoms, were randomly assigned into either an intervention group with 
ICT support (automated mobile phone messages, automated emails, and continued feedback 
through the program); an intervention group with ICT support plus human support (brief weekly 
support phone call without clinical content); or a waiting-list control. At pre-, post-, and 12-month 
follow-up, they completed depression, anxiety, positive and negative effect, and perceived stress 
measures. Results were analyzed using both intention-to-treat and completers data. The majority 
were women (67.7%), with a mean age of 35.6 years (standard deviation =9.7). 
Results: The analysis showed that the two intervention groups improved significantly pre- to 
posttreatment, compared with the control group. Furthermore, improvements were maintained 
at the 12-month follow-up. Adherence and satisfaction with the program was high in both 
conditions.
Conclusion: The Internet-based program was effective and well accepted, with and without 
human support, showing that ICT-based automated support may be useful. It is essential to 
continue to study other ICT strategies for providing support.
Keywords: online intervention, types of support, depressive symptomatology, adherence, 
satisfaction
Introduction
Depression is one of the most prevalent and disabling psychological disorders 
worldwide1,2 and is found to be the second leading cause of disability worldwide.3 The 
epidemiological magnitude of this disease,1 its special tendency toward chronicity,4 the 
high rate of comorbidity,5 and the high personal, social, and economic costs6 suggest 
that prevention and treatment of depression should be a health priority.7 Some research 
studies have shown a significant relationship between stress, clinical symptomatology, 
and depression.8,9 It is universally accepted that adverse life events, along with biology 
and the environment, can cause mental health problems.10 Stressful circumstances, 
such as difficult social and psychological circumstances, make people feel anxious, 
sad, worried, and unable to cope, damaging their physical and psychological health. 
Thus, if people feel tense too often or the tension goes on for too long, they become 
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more vulnerable to suffer from depression.11 Psychological 
processes have been found to mediate the impact of familial 
risk, social circumstances, and life events on mental health.10 
Therefore, in order to prevent depression, it is important to 
develop strategies to improve these psychological processes 
through the promotion of adaptive strategies to regulate 
emotion and resilience in people exposed to high levels of 
stress. As the European Pact for Mental Health and Well-
being states, prevention of depression is a key issue and a 
health priority.12
There are evidence-based psychological interventions 
for depression.13 In fact, depression can be treated effec-
tively with pharmacological interventions, psychotherapy, 
especially cognitive behavioral therapy (CBT), or a combi-
nation of the two.14,15 However, these interventions have an 
important limitation: the mental health services provided 
are generally less than adequate in terms of accessibility 
and quality.16 Less than 50% of people with depression are 
treated by a health professional or general practitioner, and 
only a quarter receive appropriate treatment, because of 
the costs and demands of face-to-face treatments, the time 
required for their application, or the lack of well-trained 
professionals.17,18 Therefore, individual psychotherapy, 
the dominant model in providing services, is not likely to 
meet these needs.16,19 Information and communication tech-
nologies (ICTs), especially with the use of the Internet to 
support the implementation of interventions, have proven 
to be a powerful vehicle for their effective deployment in 
providing general mental healthcare.18,20 Today, Internet-
based interventions seem to be a very promising alternative 
to current routine treatment strategies for depression.21 
Meta-analyses have demonstrated the clinical effectiveness 
of Internet-based treatments for depression.22,23 They have 
been shown to be a feasible solution and a useful strategy 
to promote dissemination, solve accessibility problems, and 
facilitate the delivery of interventions.19,24 According to the 
stepped-care model considered by the National Institute 
for Health and Care Excellence guidelines for people with 
sub-threshold depressive symptoms or mild to moderate 
depression (step 2), it is important to consider offering indi-
vidual guided self-help based on the principles of CBT or 
computerized CBT.25
An additional benefit of Internet-based interventions is 
that therapist time is greatly reduced compared with face-to-
face therapy.26 Although data on Internet-based interventions 
are consistent and promising, this field is still new,27 and there 
are important problems to solve. For instance, it is unclear 
which patients can benefit the most from Internet-based 
interventions, and dropout rates are higher than those in 
face-to-face treatment. Dropout rates in Internet-based 
treatment programs ranges from 2% to 83%, with a median 
of 19% and a weighted average of 31%,28 which are due to 
various causes, one of which may be human support not 
being provided.29 Recently, a growing amount of research 
has been conducted to determine the role of human support 
in these interventions, and the literature shows the importance 
of providing this support.23 Meta-analytic studies have found 
that Internet-based treatments with support produce greater 
effect sizes and lower dropout rates than Internet-based 
programs without any support.23,30 Higher dropout rates 
have been found in unguided web-based interventions for 
depression, compared with guided web-based interventions, 
with average adherence levels estimated at 26% in unguided 
interventions and 72% in guided interventions.23 However, 
studies usually refer to support that is administered by a per-
son (therapist, consultant, or researcher), rather than support 
that can be provided automatically by the system through 
ICTs (automated reminders, feedback provided by the pro-
gram, emails, or mobile SMS).23 Unguided interventions 
have been shown to be much easier to implement and less 
costly than guided Internet-based interventions,31 and hence, 
it is important to continue to study their effectiveness. As 
Newman et al32 noted, minimal contact therapies have been 
proposed as effective and low-cost interventions for anxiety 
and mood disorders. According to these authors, it is essential 
to continue to study whether human support is necessary for 
therapeutic efficacy and differentiate this human support 
(which consumes more resources) from the automated sup-
port provided by the system itself. 
Taking all of these into consideration, the main objective 
of the present study is to investigate the efficacy of an 
Internet-based program for depressive symptoms applied 
using only ICT-based automated support or using this same 
kind of support, but enhanced by human support. To do so, 
an Internet-based program designed to provide automated 
support and feedback to patients throughout the intervention 
was developed, and a randomized control trial (RCT) with 
three experimental conditions was performed: two interven-
tion groups (one with ICT support alone and the other with 
ICT support plus human support) and a waiting list control 
group. The main hypothesis is that the participants in both 
the intervention groups, regardless of the type of support 
received (ICT-based automated support or ICT plus human 
support), will show significant improvements compared with 
the control group, and the improvements will be maintained 
at the 12-month follow-up. Furthermore, it was hypothesized 
that adherence and satisfaction will be high in both the 
intervention conditions.
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Patients and methods
participant characteristics and sampling 
procedures
Participants were recruited through announcements in the 
university community, advertisements in the media (Internet 
and newspapers), and posters in the Valencia area (Spain). 
Sample selection and recruitment began in March 2012 and 
ended in December 2012. People who were interested con-
tacted the authors through phone or email. Inclusion criteria 
were age between 18 and 65 years, willingness to participate 
in the study, ability to use a computer and having an Internet 
connection at home, ability to understand and read Spanish, 
currently experiencing at least one stressful event in their 
lives that produced interference, and having depressive 
symptoms (score of #28 on the Beck Depression Inventory-II 
[BDI-II]). Exclusion criteria were currently receiving psy-
chological treatment, having received another psychological 
treatment in the past year, and having a severe Axis I mental 
disorder: abuse or dependence on alcohol or other sub-
stances, psychotic disorder or dementia, and the presence 
of suicidal ideation or plan (evaluated by Mini-International 
Neuropsychiatric Interview [MINI]). The study was approved 
by the Ethics Committee of Jaume I University. 
The total final study sample was composed of 124 partici-
pants, mostly women (67.7%). The mean age was 35.60 years 
(standard deviation [SD]: 9.70; range: 20–59 years). 
Table 1 provides additional demographic information of 
the participants.
All the participants experienced one or more stressful 
events in their lives which produced interference, and many 
of them had clinically significant depressive symptoms. The 
most common stressful event was unemployment (83.6%). 
The sample also presented other stressful situations (unem-
ployed relatives [63.7%], debts [47.58%], disease [own or 
relatives, 62.90%], conflicts [work/family, 64.52%]).
In addition to experiencing these complicated situations 
with low mood and depression symptoms, 33 participants met 
the emotional disorder (ED) criteria, based on the Diagnostic 
and Statistical Manual of Mental Disorders, 4th edition, 
Text Revision (DSM-IV-TR) criteria (American Psychiatric 
Association):33 14 participants had depression (mild to 
moderate, 8 of them only had depression and 6 had comorbid 
depression with another anxiety disorder); 4 participants 
had dysthymia (3 of them had only dysthymia and 1 had 
comorbid dysthymia with another anxiety disorder); and 
15 participants had anxiety disorder combined with mild to 
moderate depressive symptoms (13 of them had only one 
diagnosis and 2 of them had a comorbid diagnosis).
Sample size, power, and precision
To collect the sample, power calculations indicated that a 
sample size of 26 participants in each group (78 in all) would 
be sufficient to detect an effect size of d =0.70 with a power 
of 80%, which was the minimum expected, based on a similar 
study.34 As Internet interventions tend to result in relatively 
high dropout rates of up to 30%,24 this study aimed for 
34 participants in each group, that is, taking into account the 
three experimental conditions, at least 102 participants in all.
intervention
A manualized treatment protocol called Sonreír es Divertido 
(in English: Smiling is Fun) was developed, which included 
therapeutic components of evidence-based treatments and 
had previously been tested in another study within the 
framework of the European online predictive tools for 
intervention in mental illness project.35 The program is 
based on the transdiagnostic perspective. Specifically, it has 
some of the components of the unified protocol: motivation, 
psychoeducation, cognitive therapy, and relapse preven-
tion.8 Furthermore, it incorporates a behavioral activation 
component.36 The program also includes a component of 
positive psychology, offering strategies to promote and 
enhance positive mood.37,38 The whole protocol stresses the 
importance and benefits of being active and being involved 
in life, values, and goals. It allows the individual to learn and 
practice adaptive ways to cope with depressive and anxiety 
symptoms and confront daily problems. The protocol was 
Table 1 Demographic characteristics of participants at pre-
assessment
Variables IG IGHS WL Total
Gender
Male 13 (36.1%) 15 (34.1%) 12 (27.3%) 40 (32.3%)
Female 23 (63.9%) 29 (65.9%) 32 (72.7%) 84 (67.7%)
Marital status 
Single 20 (55.6%) 23 (52.3%) 20 (45.5%) 63 (50.8%)
Married/with 
partner
12 (33.3%) 19 (43.2%) 20 (45.5%) 51 (41.1%)
Divorced 4 (11.1%) 2 (4.5%) 4 (9.1%) 10 (8.1%)
education level
High school 
graduate or less
1 (2.8%) 3 (6.8%) 3 (6.8%) 7 (5.6%)
Some college 9 (25%) 12 (27.3%) 7 (15.9%) 28 (22.6%)
College graduate 
or graduate degree
26 (72.2%) 29 (65.9%) 34 (77.3%) 89 (71.8%)
age
rank 20–59 20–53 21–58 20–59
M 35.22 35.05 36.48 35.60
SD 9.70 9.36 10.17 9.70
Abbreviations: M, mean; SD, standard deviation; iG, intervention group (N=36); 
iGHS, intervention group with human support (N=44); Wl, waiting list control 
condition (N=44).
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adapted to a completely self-help Internet-based, multime-
dia (video, image, etc), interactive program. It is designed 
for optimal use on a personal computer, but it can also be 
used on a tablet (https://www.sonreiresdivertido.com/). 
intervention protocol modules
The intervention protocol consists of eight interactive mod-
ules. As Table 2 shows, each module has specific objectives 
(for more information about the program, see Botella et al35). 
The program has two additional modules: the “Home 
module” (Figure S1), which explains who we are, the terms 
and conditions, the goal of Smiling is Fun and who can benefit 
from it; the “Welcome module”, which explains the content 
of each module and how to benefit from it.
iCT-support transversal tools
The intervention program uses three complementary 
transversal tools that accompany the user throughout its 
implementation. These tools provide useful feedback that is 
important for participants’ motivation and reinforcement: 
1) The Activity report for self-monitoring gives users 
feedback, showing them that there is a relationship between 
their mood and the activities performed, as well as the 
benefits of being active. First, users have to rate their mood 
state, stress, and coping ability on a scale from 0 to 10. 
Then, they have to indicate their degree of satisfaction with 
each activity in the past 24 h, and how much these activi-
ties are related to their life values and goals. Furthermore, 
users have to indicate what percentage of the day they have 
been actively involved in their lives (Figure S2). 2) The 
Calendar allows users to know what step of the program 
they are on, and it gives them information about homework 
and tasks already completed, reminding them about those 
still pending. Furthermore, the Calendar indicates which 
days each participant has completed the activity report 
(Figure S3). 3) “How am I?” provides a set of graphs and 
feedback to chart the user’s progress, showing information 
about the activity level, emotional distress (anxiety and sad-
ness), positive emotionality (active, enthusiastic, energetic, 
etc), and negative emotionality (angry, fearful, stressed, 
tense, moody, etc). This tool allows participants to graphi-
cally visualize the relationships among their activity level, 
mood state, stress, and coping ability (Figure S4). Regarding 
the intervention use, participants progressed sequentially 
through the intervention program in a completely self-applied 
way over the Internet at their own pace, but they were told 
that they would obtain the most benefit from the program if 
they did about one module per week. This is the time each 
module was designed to be completed. The participants 
knew that they had a maximum of 12 weeks for completing 
all eight modules, because of the individual differences in 
everyone’s rhythm. During the progress of the intervention, 
when they finished one module, if they wanted they were 
allowed to look over it again (Figure S5). In the control 
group, the participants completed the pre-assessment, and 
12 weeks later, the post-assessment, after which, they can 
also access the program.
Structured support protocol
We developed a structured protocol for the type of sup-
port provided to participants during the implementation of 
the program (Figure S5 and Supplementary material). All 
the participants received ICT support. Furthermore, one 
group of participants received human support as well. The 
ICT support consisted of two weekly, automated mobile 
phone messages encouraging them to proceed with the 
program and reminding them of the importance of doing 
the tasks in each module and the Activity report every day 
(Figure 1). Several different alternating messages were sent 
(Supplementary material). Furthermore, the participants 
received an automated email encouraging them to continue 
with the modules if they had not accessed the program for 
a week. In addition to this automated support, the program 
offered continued feedback to users through the transversal 
tools described earlier.
The human support consisted of a 2 min, weekly support 
call by the therapist (once a week, with no clinical content). 
The objective of this brief call is to tell the participants 
whether they are making good progress through the program 
modules (motivating the participants if they advance slowly 
or offering positive reinforcement if they advance at a good 
pace, etc) and to indicate the importance of doing the tasks 
in each module and the Activity report every day (Figure 1 
and Supplementary material). It should be emphasized that 
the content of the support was not clinical, and the therapist 
received training in this type of support. 
Therapists
All the therapists (4) involved in the study were experienced 
clinical psychologists (with at least a master degree or PhD) 
trained in CBT and with extensive experience in treatment 
using Internet-based interventions. The clinical psychologists 
applied the MINI by telephone to establish each participant’s 
clinical diagnosis under the supervision of two senior clinical 
psychologists. They also made the two weekly support phone 
calls to the participants in the “human support” group. They 
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Figure 1 Structured protocol for the type of support provided to participants.
Abbreviation: iCT, information and communication technology.
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(QFRXUDJLQJWKHPWRSURFHHGZLWKWKHSURJUDP5HPLQGWKHPWRFDUU\RXWWKHWDVNVLQHDFKPRGXOH
D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were trained in the use of the “human support protocol” 
developed in the study.
Measures
The measures used in the study are diagnostic interview (at 
pre-assessment, by phone or face to face at university clinical 
center, depending on whether or not participants were close 
to the university clinical center).
MiNi
This is a short, structured diagnostic psychiatric interview 
that yields key DSM-IV and ICD-10 diagnoses.39 It has 
excellent interrater reliability, ranging from 0.88 to 1.00.40 
It has been translated and validated in Spanish.41 Participants 
were interviewed by telephone to determine their current 
ED diagnosis using the MINI, as in previous studies on 
Internet-based interventions.42
primary outcome measure (at pre-, post-, and 
follow-up assessment, over the internet)
BDi-ii
The BDI-II is a 21-item self-report scale of depressive symp-
toms.43 The questionnaire has shown good psychometric 
properties in several studies.44 The Spanish version of the 
BDI-II was used.45 It shows good reliability and validity 
data and provides a bifactorial solution that matches what 
was found in previous studies.45 It has shown high internal 
consistency for both general (α=0.87) and clinical popula-
tions (α=0.89).45 Cronbach’s alpha in the present study was 
excellent (α=0.88).
Secondary outcome measures (at pre-, post-, and 
follow-up assessment, over the internet)
overall anxiety Severity and impairment Scale (oaSiS)
The OASIS46 consists of five items that measure the fre-
quency and severity of anxiety, as well as the level of 
avoidance, work/school/home interference, and social 
interference associated with anxiety. It has been found to 
have excellent test–retest reliability, in addition to good 
convergent and discriminant validity and high internal con-
sistency (α=0.80).46 The OASIS was translated to Spanish, 
and a validation process as performed.47 The validation data 
confirmed the factorial structure and reliability and the valid-
ity data obtained by the original authors.46 Cronbach’s alpha 
in the present study was excellent (α=0.87).
overall Depression Severity and impairment Scale 
(oDSiS)
The ODSIS is a self-report measure with five items that 
evaluate experiences related to depression.7 It measures the 
frequency and severity of depression, as well as the level of 
avoidance, work/school/home interference, and social inter-
ference associated with depression. It was found to have good 
convergent and discriminant validity and excellent internal 
consistency (α=0.94 in the outpatient sample, 0.91 in the 
student sample, and 0.92 in the community sample).7 The 
ODSIS was translated to Spanish, and a validation process 
was performed.48 The validation data confirmed the factorial 
structure and reliability and the validity data obtained by the 
original authors.7 Cronbach’s alpha in the present study was 
excellent (α=0.92).
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positive and Negative affect Schedule (paNaS)
The PANAS consists of 20 items that evaluate two inde-
pendent dimensions: positive affect (PANAS+) and nega-
tive affect (PANAS-). The range for each scale (10 items 
on each) is from 10 to 50.49 It is a brief, reliable, and valid 
self-report measure. It has shown excellent convergent and 
divergent validity.49 The validation of the Spanish PANAS 
revealed, like the original version, a robust and stable two-
dimensional structure (PANAS+ and PANAS-) and provided 
strong support for its validity and reliability (internal con-
sistency: 0.89–0.91 for PANAS+ and PANAS- in women 
and 0.87 for PANAS+ and 0.89 for PANAS- in men).50 In 
the present study, Cronbach’s alphas for PANAS+ (α=0.94) 
and PANAS- (α=0.88) were excellent.
perceived Stress Scale (pSS)
The PSS is a 14-item self-report questionnaire that assesses 
the degree to which recent life situations are appraised as 
stressful.51 In the present study, a 4-item PSS (PSS-4) was 
used. This PSS-4 was introduced as a brief version for situ-
ations requiring a very short scale or telephone interviews.52 
It has been validated in different studies, showing an 
internal consistency reliability of 0.76–0.82.53 The Spanish 
validation of the PSS-14 and PSS-10 had good psychometric 
proprieties,54 but the Spanish validation of the PSS-4 did not; 
however, it was used because it was administrated over the 
Internet. Cronbach’s alpha in the present study was α=0.65.
Treatment acceptance measures (expectations at the 
end of module 2 and satisfaction at post assessment, 
over the internet)
Treatment expectations and satisfaction scales
This questionnaire measures participants’ expectations 
before treatment and their satisfaction after receiving it.55 It 
includes five items rated from 0 (“not at all”) to 10 (“very 
much”); the questions address how logical the treatment 
seems, to what extent the patient is expected to be satisfied 
with it, whether the patient would recommend the treatment 
to others, whether it would be useful in treating other prob-
lems, and the treatment’s usefulness for the patient’s problem. 
Participants answered the expectations scale after module 2 
of the program. The satisfaction scale was completed once 
the treatment was over. This adaptation has been used in 
previous studies.56,57
research design
This is a RCT with three experimental conditions. 1) Inter-
vention group with ICT support (IG): participants had access 
to the Internet-based intervention program and received only 
ICT-based automated support. 2) Intervention group with 
ICT-based automated support plus human support (IGHS): 
participants had access to the Internet-based intervention 
program with the same intervention modules and the same 
transversal tools as the other group, and they received ICT 
support plus human support. The participants in both the 
intervention groups had a maximum of 12 weeks to finish 
the intervention program. 3) Waiting list control group 
(WL): the participants waited 12 weeks, and then they were 
offered the chance to receive the treatment. If they agreed, 
they could access the program and were randomly assigned 
to one of the intervention conditions (IGHS or IG). Measure-
ments were obtained at three time points: prior to the treat-
ment, at posttreatment, and at 12-month follow-up. 
The random assignment of the participants to the different 
experimental conditions was generated by an independent 
researcher who had no knowledge about the study or the 
intervention received in the different groups. This inves-
tigator performed the randomized assignment according 
to a randomization list created by the Random Allocation 
Software, version 1.0. Participants were stratified based 
on the severity of depressive symptoms. The study was 
registered in the National Institute of Health Registration 
System of the United States of America with Clinical Trial 
Registration Number: NCT02148354 (http://ClinicalTrials.
gov/ct2/show/NCT02148354). The CONSORT-EHEALTH 
guidelines were followed to compare the three experimental 
conditions included in the study.
Statistics and data analysis
Group differences in demographic data and pretreatment 
measures were analyzed with one-way analysis of variance 
(ANOVA) and chi-square tests, in order to determine whether 
there were significant differences among the groups. The 
outcome analyses were limited to participants who entered 
the intervention and did the pretreatment assessment. Those 
who did not enter the intervention or complete the pretreat-
ment assessment were excluded, as their outcomes, positive 
or otherwise, could not be indicative of the effectiveness of 
the intervention, following other relevant authors in the field.58 
Two sets of analyses were carried out. The first one only 
examined observed data (completer participants); individu-
als who did not provide data for the follow-up period were 
excluded. The second set employed an intention-to-treat (ITT) 
analysis. Thus, posttreatment and follow-up improvement were 
investigated separately for the completer and ITT samples. 
Data considering the ITT sample were also analyzed to study 
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whether the results were similar to those obtained with the 
completer sample. In order to test treatment efficacy, mixed 
ANOVAs with repeated measures were used to compare the 
time effect on the measures (pre- to posttreatment, and pre-, 
post-, 12-month follow-up) and the time interactions among the 
treatment conditions. The ANOVAs were followed by Sidak’s 
corrected post hoc tests when needed. Because differences in 
the three experimental groups were found at pretreatment on 
the PSS variable, they were analyzed using univariate analyses 
of covariance (ANCOVAs), assigning pretreatment scores 
as the covariate. Effect sizes (Cohen’s d) were calculated for 
within- and between-group changes, based on the pooled SD. 
The expectation and satisfaction scores were also analyzed by 
using mixed ANOVAs with repeated measures. Correlation 
analysis was performed to explore the relationship between 
adherence and the different outcome measures at posttreat-
ment. All statistical analyses were conducted by using IBM 
SPSS Statistics 20 (IBM Corporation, Armonk, NY, USA).
procedure
People interested in the study contacted us by phone or by 
email. Possible participants were prescreened through phone 
calls to filter some crucial inclusion and exclusion criteria: 
age, receiving psychological treatment or having received 
another psychological treatment in the past year, being able 
to use a computer, having an Internet connection at home, 
and being able to understand and read Spanish. Participants 
who passed the prescreening through phone were given a 
date for an initial face-to-face interview (or through phone, 
depending on where the participant lived), where a research 
team member explained the study. Participants interested in 
participating signed an informed consent form (in person 
or on the Internet). Subsequently, the investigator asked for 
demographic information, administered the BDI-II, deter-
mined the current ED diagnosis using the MINI, and gathered 
further information about inclusion and exclusion criteria. 
The selected participants were then randomly assigned to one 
of three experimental conditions, and the participants in the 
two intervention conditions were given access to the program. 
With their username and password, they could access the 
program and perform the pretreatment assessment integrated 
in the web system (the participants in the WL condition 
had the same evaluation outside the system, but also over 
the Internet using Survey Monkey). The IGHS participants 
received a telephone call reminding them to enter the web 
system to do the pretreatment assessment. In addition, the 
WL group participants received a telephone call reminding 
them to do the pretreatment assessment.
When participants completed the eight treatment modules, 
they performed the posttreatment evaluation, also integrated 
in the web system (same self-report questionnaires as in 
the pretreatment assessment, plus the treatment satisfaction 
scale). They had a maximum of 12 weeks to complete the 
intervention program. 
Finally, 12 months after the posttreatment assessment, the 
participants completed the 12-month follow-up assessment. 
Participants in the control condition performed the pretreat-
ment assessment, but they had no access to the program con-
tent and did not receive any intervention for 12 weeks. After 
this waiting period, they were assessed again, and, if they 
wished to, they could access the program and were randomly 
assigned to one of the two intervention conditions.
Results
Participant flow
Regarding the flow of participants throughout the investi-
gation process, Figure 2 shows that 481 people were inter-
ested in the study. They were contacted through telephone 
(prescreening) to explain their participation in the study 
and filter some crucial criteria, described in the Procedure 
section. After this phone call, 204 were not interested or 
did not answer the phone call, and 72 did not meet some 
of the minimum criteria tracked by phone. Thus, 205 
people were invited to participate and performed the initial 
interview, but 73 of them did not meet the inclusion and 
exclusion criteria. Finally, 132 participants were assigned 
to the three experimental conditions: IG, n=44; IGHS, 
n=44; WL, n=44. We had pretreatment assessments for 36 
participants in the IG, 44 participants in the IGHS, and 44 
participants in the WL. During the intervention program, 
8 participants dropped out of the IG group and 8 dropped 
out of the IGHS group. 
pretreatment data
Table 1 shows the demographic characteristics of each 
experimental condition at pretreatment. The results indi-
cated that there were no significant differences between 
the experimental groups before treatment on any of these 
variables: gender (χ2 [1] =0.813; P=0.666); marital status 
(χ2 [2] =2.351; P=0.671); educational level (χ2 [2] =2.526; 
P=0.640); and age (F
(2,121)
 =0.276; P=0.759).
Regarding the clinical characteristics of the participants 
in each experimental condition at pretreatment (Table 3), 
the data indicated that there were no significant differences 
among the three experimental groups on any of the variables 
before treatment, with the exception of perceived stress 
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Figure 2 Flowchart of study.
Abbreviations: iG, intervention group; iGHS, intervention group with human support; Wl, waiting list control condition.
(F
(2,121)
 =8.53, P,0.001). In relation to this variable, the post 
hoc analysis (Tukey’s HSD) revealed that the WL group 
was significantly different from the other two experimental 
conditions (IG and IGHS). That is, the WL group had a 
statistically significant higher score on the PSS variable 
than the two intervention groups, but these two interven-
tion groups were not significantly different from each 
other. As noted earlier, all the participants (in the three 
experimental conditions) experienced at least one stressful 
event in their lives.
Differential effectiveness of three 
experimental conditions: change in 
primary and secondary outcomes pre- 
and posttreatment
Means, SDs, within-group and between-group effect sizes, 
and confidence intervals for all the outcome measures in the 
three experimental groups are summarized in Table 4, for 
both completer and ITT analyses.
The analysis to test for mean differences in the different 
measures was a 3 (group) ×2 (time) mixed ANOVA with 
repeated measures in the second factor.
Regarding the completer sample, the analyses revealed a 
significant effect of time on all the outcome measures: BDI-II 
(F
(1,105)
 =44.63, P,0.001), OASIS (F
(1,105)
 =26.28, 
P,0.001); ODSIS (F
(1,105)
 =19.58, P,0.001); PANAS- 
(F
(1,105)
 =22.34, P,0.001) and PANAS+ (F
(1,105)
 =6.50, 
P=0.012). The effect of group was not statistically signifi-
cant in any variable. Furthermore, the analyses revealed 
a significant interaction effect: BDI-II (F
(2,105)
 =8.85, 
P,0.001), OASIS (F
(2,105)
 =11.87, P,0.001), ODSIS 
(F
(2,105)
 =5.37, P=0.004), PANAS- (F
(2,105)
 =7.41, P=0.001), 
and PSS (F
(2,105)
 =5.30, P=0.006), except in the case of 
PANAS+ (F
(2,105)
 =1.75, P=0.180). Regarding the interac-
tions: Sidak’s corrected post hoc tests indicated that both 
the intervention groups experienced significant improve-
ments in all variables during the intervention, with the 
exception of PANAS+. The control group did not improve 
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pre- to posttreatment on any of the variables. Regarding the 
PSS variable, an ANCOVA was performed to control for 
differences found among the three experimental groups at 
pretreatment. Covariate analysis indicated that the groups 
differed significantly at posttreatment (F
(2,104)
 =18.005, 
P,0.001). Sidak’s post hoc test indicated that the two 
intervention groups significantly improved their perceived 
stress pre- to posttreatment; nevertheless, the control 
group did not improve pre- to posttreatment on this vari-
able. Regarding the ITT sample, the analysis revealed 
the same pattern of results as in the completer sample. 
They showed a significant effect of time on all variables: 
BDI-II (F
(1,121)
 =35.98, P,0.001), OASIS (F
(1,121)
 =26.35, 
P,0.001); ODSIS (F
(1,121)
 =16.62, P,0.001); PANAS+ 
(F
(1,121)
 =5.93, P=0.016), and PANAS- (F
(1,121)
 =22.29, 
P,0.001). The effect of group was not statistically sig-
nificant on any variable. Furthermore, analysis revealed 
a significant interaction effect on these measures: BDI-II 
(F
(2,121)
 =6.09, P=0.003), OASIS (F
(2,121)
 =10.86, P,0.001), 
ODSIS (F
(2,121)
 =4.08, P=0.019), PANAS- (F 
(2,121)
 =7.10, 
P,0.001), except in the case of PANAS+ (F
(2,121)
 =1.18, 
P=0.310). Sidak’s post hoc tests indicated that both the 
intervention groups experienced significant improvements 
in all variables. This improvement was not found in the 
waiting list control group. Regarding the PSS variable, an 
ANCOVA was performed to control for differences found 
among the three experimental groups at pretreatment. 
Covariate analysis indicated that the groups differed 
significantly at posttreatment (F
(2,121)
 =11.908, P,0.001). 
Sidak’s post hoc test indicated that the two intervention 
groups significantly improved their perceived stress pre- to 
posttreatment, whereas the control group did not improve 
pre- to posttreatment on this variable. 
Differential effectiveness of the two 
intervention conditions in maintaining 
the improvements at 1-year follow-up
Means and SDs for all the outcome measures in the two 
intervention groups at pre-post and follow-up (12 months) 
are summarized in Table 5. 
Regarding the completer sample, the analysis revealed a 
significant time effect on all measures: BDI-II (F
(2,86)
 =24.58, 
P,0.001); OASIS (F
(2,86)
 =10.36, P,0.001); ODSIS 
(F
(2,86)
 =12.46, P,0.001), PANAS+ (F
(2,86)
 =8.01, P,0.001), 
PANAS- (F
(2,86)
 =30.08, P,0.001), and PSS (F
(2,86)
 =9.47, 
P,0.001). The analysis did not reveal a significant group 
effect or a significant interaction effect on any measure. 
Regarding the ITT sample, the analysis revealed the same 
pattern of results as the completer sample, a significant time 
effect on all measures: BDI-II (F
(2,156)
 =29.03, P,0.001), 
OASIS (F
(2,156)
 =22.94, P,0.001); ODSIS (F
(2,156)
 =14.74, 
P,0.001), PANAS+ (F
(2,156)
 =10.41, P,0.001), PANAS- 
(F
(2,156)
 =39.34, P,0.001), and PSS (F
(2,156)
 =13.73, P,0.001). 
The analysis did not reveal a significant group effect or a 
significant interaction effect on any measure. 
adherence and modules completed
Regarding adherence, 77.77% of participants completed all 
the modules in the IG group, and 81.81% of the IGHS group 
did so. There were no significant differences between the 
experimental groups in the dropout rate (χ2=0.202; df =1; 
P=0.653). The average number of modules completed was 
7.30 (SD =1.60). The number of modules completed was 
weakly correlated with posttreatment BDI scores (Pearson’s 
r=-0.652, P,0.01), OASIS scores (Pearson’s r=-0.480, 
P,0.01), PANAS- scores (Pearson’s r=-0.382, P,0.01), 
and PSS scores (Pearson’s r=-383, P,0.01).
Table 3 Clinical characteristics of participants at pre-assessment
Dependent 
variable
Condition M SD F(2,121) P-value
BDi-ii iG
iGHS
Wl
Total
9.14
10.91
9.11
9.76
7.66
6.96
7.47
7.34
0.84 0.436
oaSiS iG
iGHS
Wl
Total
4.06
4.43
3.00
3.81
3.65
3.66
3.04
3.47
2.02 0.137
oDSiS iG
iGHS
Wl
Total
2.53
3.30
2.27
2.71
3.16
3.52
3.34
3.35
1.10 0.336
paNaS+ iG
iGHS
Wl
Total
29.22
27.86
29.34
28.78
8.72
6.91
7.92
7.79
0.47 0.625
paNaS- iG
iGHS
Wl
Total
18.11
19.50
17.68
18.45
6.85
5.95
6.10
6.28
1.00 0.372
pSS iG
iGHS
Wl
Total
5.86
6.25
8.07
6.78
2.74
3.24
1.59
2.76
8.53 ,0.001
Abbreviations: M, mean; SD, standard deviation; iG, intervention group (N=36); 
iGHS, intervention group with human support (N=44); Wl, waiting list control 
condition (N=44); BDi-ii, Beck Depression inventory-ii; oaSiS, overall anxiety 
Severity and impairment Scale; oDSiS, overall Depression Severity and impairment 
Scale; paNaS+, positive affect Scale; paNaS-, Negative affect Scale; pSS, perceived 
Stress Scale.
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Table 4 Means, SDs, within-group, and between-group effect sizes for the outcome measures at pre- and posttreatment (completer 
and iTT sample)
N; mean (SD) Within-group effect 
size, d (95% CI)
Between-group effect size, d  
(95% CI)
Pretreatment Posttreatment
Completers at posttest (N=108)
BDi-ii iG 
iGHS
Wl 
Total
28; 8.32 (7.13)
36; 10.36 (7.28)
44; 9.11 (7.47)
108; 9.32 (7.30)
28; 3.04 (2.74)
36; 4.56 (4.39)
44; 8.45 (7.32)
108; 5.75 (5.93)
0.72 (0.17; 1.26)
0.78 (0.40; 1.16)
0.09 (-0.10; 0.28)
iG vs iGHS
iG vs Wl
iGHS vs Wl
0.40 (-0.90; 0.10)
0.90 (-1.40; -0.40)
0.62 (-1.74; -0.17)
oaSiS iG 
iGHS
Wl 
Total
28; 3.64 (3.68)
36; 4.28 (3.87)
44; 3.00 (3.04)
108; 3.59 (3.51)
28; 1.46 (2.13)
36; 1.08 (1.73)
44; 3.34 (3.77)
108; 2.10 (2.99)
0.58 (0.13; 1.01)
0.81 (0.32; 1.29)
0.11 (-0.32; 0.10)
iG vs iGHS
iG vs Wl
iGHS vs Wl
0.19 (-0.29; 0.69)
0.57 (-1.06; -0.09)
0.74 (-1.20; -0.28)
oDSiS iG 
iGHS
Wl 
Total
28; 2.29 (3.16)
36; 3.17 (3.68)
44; 2.27 (3.34)
108; 2.57 (3.41)
28; 0.54 (1.32)
36; 0.72 (1.75)
44; 2.23 (3.57)
108; 1.29 (2.68)
0.54 (0.02; 1.05)
0.65 (0.19; 1.10)
0.01 (-0.22; 0.25)
iG vs iGHS
iG vs Wl
iGHS vs Wl
0.11 (-0.60; 0.38)
0.57 (-1.06; -0.09)
0.51 (-0.96; -0.07)
paNaS+ iG 
iGHS
Wl 
Total
28; 30.32 (8.91)
36; 28.19 (6.96)
44; 29.34 (7.92)
108; 29.21 (7.86)
28; 32.50 (8.51)
36; 32.97 (8.24)
44; 29.91 (7.58)
108; 31.60 (8.10)
0.24 (-0.18; 0.65)
0.67 (0.29; 1.04)
0.07 (-0.31; 0.46)
iG vs iGHS
iG vs Wl
iGHS vs Wl
0.05 (-0.44, 0.54)
0.32 (-0.80; 0.15)
0.38 (-0.83; 0.06)
paNaS- iG 
iGHS
Wl 
Total
28; 18.07 (7.19)
36; 19.03 (6.19)
44; 17.68 (6.10)
108; 18.23 (6.40)
28; 13.04 (3.32)
36; 13.19 (3.82)
44; 17.93 (6.80)
108; 15.08 (5.63)
0.68 (0.22; 1.13)
0.92 (0.51; 1.33)
0.04 (-0.44; 0.36)
iG vs iGHS
iG vs Wl
iGHS vs Wl
0.04 (-0.53; 0.45)
0.84 (-1.34; -0.35)
0.82 (-1.28; -0.37)
pSS iG 
iGHS
Wl 
Total
28; 5.64 (2.73)
36; 6.03 (3.32)
44; 8.07 (1.59)
108; 6.76 (2.78)
28; 4.25 (2.35)
36; 4.33 (3.23)
44; 8.09 (1.70)
108; 5.84 (3.08)
0.49 (0.13; 0.85)
0.50 (0.13; 0.86)
0.01 (-0.31; 0.29)
iG vs iGHS
iG vs Wl
iGHS vs Wl
0.02 (-0.52; 0.46)
1.92 (-2.49; -1.35)
1.49 (-1.98; -0.99)
ITT at posttest (N=124)
BDi-ii iG 
iGHS
Wl 
Total
36; 9.14 (7.66)
44; 10.91 (6.96)
44; 9.11 (7.47)
124; 9.76 (7.34)
36; 5.03 (6.09)
44; 6.16 (5.61)
44; 8.45 (7.32)
124; 6.65 (6.50)
0.52 (0.18; 0.86)
0.67 (0.35; 0.98)
0.09 (-0.10; 0.28)
iG vs iGHS
iG vs Wl
iGHS vs Wl
0.20 (-0.63; 0.25)
0.50 (-0.94; -0.05)
0.34 (-0.76; 0.07)
oaSiS iG 
iGHS
Wl 
Total
36; 4.06 (3.65)
44; 4.43 (3.66)
44; 3.00 (3.04)
124; 3.81 (3.47)
36; 1.92 (2.52)
44; 1.66 (2.47)
44; 3.34 (3.77)
124; 2.33 (3.08)
0.57 (0.21; 0.93)
0.74 (0.40; 1.08)
0.11 (-0.33; 0.11)
iG vs iGHS
iG vs Wl
iGHS vs Wl
0.10 (-0.33; 0.54)
0.43 (-0.88; 0.02)
0.52 (-0.95; -0.09)
oDSiS iG 
iGHS
Wl 
Total
36; 2.53 (3.16)
44; 3.30 (3.52)
44; 2.27 (3.34)
124; 2.71 (3.35)
36; 0.86 (1.78)
44; 1.43 (2.56)
44; 2.23 (3.57)
124; 1.55 (2.82)
0.52 (0.12; 0.90)
0.52 (0.13; 0.90)
0.01 (-0.22; 0.24)
iG vs iGHS
iG vs Wl
iGHS vs Wl
0.25 (-0.69; 0.19)
0.50 (-0.95; -0.05)
0.29 (-0.70; 0.13)
paNaS+ iG 
iGHS
Wl 
Total
36; 29.22 (8.72)
44; 27.86 (6.91)
44; 29.34 (7.92)
124; 28.78 (7.79)
36; 31.31 (9.08)
44; 31.61 (9.35)
44; 29.91 (7.58)
124; 30.92 (8.64)
0.23 (-0.10; 0.57)
0.53 (0.23; 0.83)
0.07 (-0.31; 0.45)
iG vs iGHS
iG vs Wl
iGHS vs Wl
0.03 (-0.41; 0.47)
0.17 (-0.61; 0.27)
0.20 (-0.62; 0.22)
paNaS- iG 
iGHS
Wl 
Total
36; 18.11 (6.85)
44; 19.50 (5.95)
44; 17.68 (6.10)
124; 18.45 (6.28)
36; 13.81 (3.66)
44; 14.14 (4.68)
44; 17.93 (6.80)
124; 15.39 (5.59)
0.61 (0.22; 1.00)
0.89 (0.53; 1.24)
0.04 (-0.44; 0.36)
iG vs iGHS
iG vs Wl
iGHS vs Wl
0.08 (-0.51; 0.36)
0.72 (-1.18; -0.27)
0.64 (-1.72; -0.21)
pSS iG 
iGHS
Wl 
Total
36; 5.86 (2.74)
44; 6.25 (3.24)
44; 8.07 (1.59)
124; 6.78 (2.76)
36; 4.78 (2.62)
44; 4.86 (3.32)
44; 8.09 (1.70)
124; 5.98 (3.05)
0.39 (0.01; 0.75)
0.42 (0.09; 0.74)
0.01 (-0.30; 0.28)
iG vs iGHS
iG vs Wl
iGHS vs Wl
0.02 (-0.47; 0.41)
1.51 (-2.01; -1.02)
1.20 (-1.66; -0.75)
Abbreviations: SD, standard deviation; iTT, intention-to-treat; iG, intervention group; iGHS, intervention group with human support; Wl, waiting list control condition; 
BDi-ii, Beck Depression inventory-ii; oaSiS, overall anxiety Severity and impairment Scale; oDSiS, overall Depression Severity and impairment Scale; paNaS+, positive 
affect Scale; paNaS-, Negative Affect Scale; PSS, Perceived Stress Scale; CI, confidence interval.
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expectations and satisfaction
Table 6 lists the results of both the intervention groups. All 
the scores were high before the treatment. The analysis did 
not reveal significant differences between the two groups on 
any measures: treatment logic (F
(1,74)
 =0.118, P=0.733), treat-
ment satisfaction (F
(1,74)
 =0.345, P=0.559), recommending the 
treatment to others (F
(1,74)
 =0.061, P=0.806), usefulness of the 
treatment for other psychological problems (F
(1,74)
 =1.131, 
P=0.739), and usefulness of the treatment for the patient 
(F
(1,74)
 =0.112, P=0.739).
After using the program, participants’ satisfaction scores 
were also high. The analysis did not reveal significant dif-
ferences between groups on treatment logic (F
(1,62)
 =0.109, 
P=0.742), treatment satisfaction (F
(1,62)
 =0.046, P=0.830), rec-
ommending the treatment to others (F
(1,62)
 =0.093, P=0.761), 
usefulness of the treatment for other psychological problems 
Table 5 Means, SDs, within-group and between-group effect sizes for the outcome measures at pretreatment, posttreatment, and 
12-month follow-up (completer and iTT sample)
N; mean (SD) Within-group 
effect size, 
d (95% CI)
Between-group effect size, 
d (95% CI)
Pretreatment Posttreatment Follow-up  
(12 months)
Pre-follow-up  
(12 months)
Group Follow-up  
(12 months)
Completers at 12-month follow-up (N=45)
BDi-ii iG 
iGHS
Total
20; 8.30 (7.26)
25; 10.52 (7.56)
45; 9.53 (7.42)
20; 2.60 (2.78)
25; 4.80 (4.59)
45; 3.82 (4.01)
20; 3.25 (4.10)
25; 4.04 (5.69)
45; 3.69 (5.01)
0.67 (0.11; 1.21)
0.83 (0.36; 1.29)
iG vs iGHS 0.15 (-0.74; 0.44)
oaSiS iG 
iGHS
Total
20; 3.35 (3.35)
25; 3.84 (3.84)
45; 3.62 (3.62)
20; 1.45 (2.04)
25; 0.80 (1.58)
45; 1.09 (1.81)
20; 1.65 (2.58)
25; 2.04 (2.95)
45; 1.87 (2.77)
0.49 (-0.13; 1.10)
0.45 (-0.05; 1.02)
iG vs iGHS 0.14 (-0.73; 0.45)
oDSiS iG 
iGHS
Total
20; 2.30 (2.72)
25; 3.08 (3.99)
45; 2.73 (3.47)
20; 0.40 (.883)
25; 0.64 (1.440)
45; 0.53 (1.217)
20; 0.85 (2.13)
25; 1.24 ( 2.31)
45; 1.07 (2.22)
0.51 (0.00; 1.02)
0.45 (-0.02; 0.92)
iG vs iGHS 0.17 (-0.76; 0.42)
paNaS+ iG 
iGHS
Total
20; 29.95 (10.25)
25; 28.04 (6.01)
45; 28.89 (8.13)
20; 32.25 (9.65)
25; 32.08 (8.07) 
45; 32.16 (8.71)
20; 34.50 (6.79)
25; 32.92 (6.34)
45; 33.62 (6.52)
0.43 (-0.08; 0.93)
0.79 (0.33; 1.23)
iG vs iGHS 0.23 (-0.83; 0.35)
paNaS- iG 
iGHS
Total
20; 17.35 (6.12)
25; 19.16 (6.74)
45; 18.36 (6.46)
20; 12.60 (3.12)
25; 13.12 (3.81)
45; 12.89 (3.49)
20; 13.90 (4.28)
25; 14.28 (2.98)
45; 14.11 (3.58)
0.54 (0.13; 0.95)
0.70 (0.29; 1.10)
iG vs iGHS 0.10 (-0.69; 0.49)
pSS iG 
iGHS
Total
20; 5.60 (2.80)
25; 6.20 (3.27)
45; 5.93 (3.05)
20; 4.10 (2.34)
25; 4.52 (3.19)
45; 4.33 (2.82)
20; 4.35 (2.62)
25; 4.40 (2.43)
45; 4.38 (2.49)
0.43 (0.00; 0.86)
0.53 (0.10; 0.96)
iG vs iGHS 0.02 (-0.60; 0.57)
ITT at 12-month follow-up (N=80)
BDi-ii iG 
iGHS
Total
36; 9.14 (7.66)
44; 10.91 (6.96)
80; 10.11 (6.96)
36; 5.03 (6.09)
44; 6.16 (5.61)
80; 5.65 (5.82)
36; 5.61 (6.44)
44; 5.84 (6.51)
80; 5.74 (6.44)
0.45 (0.13; 0.76)
0.72 (0.38; 1.52)
iG vs iGHS 0.03 (-0.47; 0.40)
oaSiS iG 
iGHS
Total 
36; 4.06 (3.65)
44; 4.43 (3.66)
80; 4.26 (3.63)
36; 1.92 (2.52)
44; 1.66 (2.47)
80; 1.78 (2.48)
36; 2.33 (2.88)
44; 2.52 (3.05)
80; 2.44 (2.99)
0.46 (0.10; 0.82)
0.51 (0.14; 0.87)
iG vs iGHS 0.06 (-0.50; 0.38)
oDSiS iG 
iGHS
Total
36; 2.53 (3.16)
44; 3.30 (3.52)
80; 2.95 (3.36)
36; 0.86 (1.78)
44; 1.43 (2.56)
80; 1.18 (2.24)
36; 1.11 (2.19)
44; 1.95 (2.89)
80; 1.58 (2.61)
0.44 (0.12; 0.75)
0.38 (0.00; 0.75)
iG vs iGHS 0.32 (-0.76; 0.12)
paNaS+ iG 
iGHS
Total
36; 29.22 (8.72)
44; 27.86 (6.91)
80; 28.48 (7.76)
36; 31.31 (9.08)
44; 31.61 (9.35)
80; 31.48 (9.18)
36; 32.53 (7.66)
44; 31.93 (7.97)
80; 32.20 (7.79)
0.37 (0.02; 0.72)
0.58 (0.26; 0.89)
iG vs iGHS 0.08 (-0.51; 0.36)
paNaS- iG 
iGHS
Total
36; 18.11 (6.85)
44; 19.50 (5.95)
80; 18.88 (6.37)
36; 13.81 (3.66)
44; 14.14 (4.68)
80; 13.99 (4.23)
36; 14.94 (4.21)
44; 15.25 (4.66)
80; 15.11 (4.44)
0.45 (0.13; 0.77)
0.70 (0.36; 1.04)
iG vs iGHS 0.07 (-0.50; 0.37)
pSS iG 
iGHS
Total
36; 5.86 (2.74)
44; 6.25 (3.24)
80; 6.08 (3.01)
36; 4.78 (2.62)
44; 4.86 (3.32)
80; 4.83 (3.01)
36; 4.81 (2.80)
44; 4.77 (2.79)
80; 4.79 (2.77)
0.37 (0.10; 0.64)
0.45 (0.15; 0.73)
iG vs iGHS 0.01 (-0.43; 0.45)
Abbreviations: SD, standard deviation; iTT, intention-to-treat; iG, intervention group; iGHS, intervention group with human support; BDi-ii, Beck Depression inventory-ii; 
oaSiS, overall anxiety Severity and impairment Scale; oDSiS, overall Depression Severity and impairment Scale; paNaS+, positive affect Scale; paNaS-, Negative affect 
Scale; PSS, Perceived Stress Scale; CI, confidence interval.
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(F
(1,62)
 =0.053, P=0.818), or usefulness of the treatment for 
the patient (F
(1,62)
 =0.137, P=0.713).
Discussion
The main objective of this study was to investigate the effi-
cacy of an Internet-based program for depressive symptoms 
with ICT-based automated support and human support. 
Participants were experiencing one or more stressful events 
in their lives which produced interference and many of 
whom had clinically significant depressive symptoms. The 
results, using both the ITT procedure and the completer 
analysis procedure, showed that, on the primary outcome 
measure (BDI-II), there was a significant time effect and a 
significant interaction effect. The effect sizes on depressive 
symptomatology pre- to postintervention were medium to 
large in both the intervention groups. In the WL group, the 
effect size was minimal.
On all the other measures of negative emotionality 
(ODSIS, OASIS, and PANAS-), the analysis also revealed 
a significant time effect and a significant interaction effect, 
and the same pattern occurred for perceived stress (PSS 
variable). The effect sizes were medium to large in both 
the intervention groups on all of these variables (with the 
exception of PSS in the ITT analysis, which was smaller). 
In the WL group, the effect size was minimal on all variables. 
In the case of positive emotionality (PANAS+), the analysis 
revealed a significant time effect, but not a significant interac-
tion effect. Nevertheless, it is necessary to take into account 
that the mean scores found for PANAS+ before the treatment 
were high, falling within the range of the population with no 
mental disorder diagnosis.59 Even so, the effect sizes showed 
that PANAS+ improved, and it improved more in both the 
intervention groups than in the waiting list control group, 
where the change is almost nonexistent. The results are in 
line with those presented in systematic reviews, showing that 
treatments over the Internet and computerized treatments are 
effective interventions.18,20,22,23
Regarding the support given in the Internet-based inter-
ventions, the literature shows that Internet-based programs 
without any human support seem to have fewer benefits.18 
The review by Richards and Richardson23 also reveals that 
self-applied interventions supported by a therapist (or by 
administrative staff) work best, showing larger effect sizes. 
This conclusion also coincides with the results of the review 
by Johansson and Andersson,60 who analyzed whether 
different degrees of support can influence the results of 
Internet-based interventions. Their results showed that more 
human support produced larger effect sizes. 
Other studies have examined the efficacy of self-applied 
treatments without human support. A meta-analysis20 con-
firmed the efficacy of self-applied treatments (without any 
contact or support from a therapist, consultant, or researcher), 
compared with a control condition, for adults who met the cri-
teria for a depressive disorder. Clarke et al61 did not find dif-
ferences at posttreatment between the group that received the 
self-applied treatment plus postcard reminders and another 
group that received brief telephone calls (5 min) with the 
same content as the postal reminders. As in this study, these 
phone calls had no clinical content. Furthermore, modest but 
statistically significant improvements were found in both the 
intervention groups compared with the control group. Never-
theless, in the Clark study, the support was provided by post-
cards and not by ICTs. Farrer et al62 also showed the efficacy 
of a self-applied treatment in reducing depression with and 
without weekly telephone calls by a therapist, compared with 
standard treatment. In this case, the weekly calls (10-min 
long) had no clinical content either. However, in this study, 
there was no control group or specific protocol for the ICT 
support. Berger et al34 compared the efficacy of a self-applied 
program using two experimental conditions (without any 
support from the therapist or using weekly therapist support 
through email) versus a control group. They found that in 
Table 6 Means and SDs for expectations and satisfaction
Statements Expectations
N; mean (SD)
Satisfaction
N; mean (SD)
How logical do you think this treatment is?
Total sample 76; 7.57 (1.79) 64; 8.14 (1.56)
iG 33; 7.48 (1.64) 28; 8.21 (1.77)
iGHS 43; 7.63 (1.92) 36; 8.08 (1.40)
How satisfied are you with the treatment received?
Total sample 76; 7.28 (1.92) 64; 7.88 (1.74)
iG 33; 7.42 (1.79) 28; 7.93 (1.92)
iGHS 43; 7.16 (2.02) 36; 7.83 (1.61)
To what extent do you feel confident recommending this treatment to a 
friend who has the same problems?
Total sample 76; 7.64 (2.12) 64; 8.33 (1.79)
iG 33; 7.58 (2.03) 28; 8.25 (1.96)
iGHS 43; 7.70 (2.21) 36; 8.39 (1.68)
Do you think this treatment could be useful for treating other 
psychological disorders?
Total sample 76; 7.46 (2.00) 64; 8.09 (1.76)
iG 33; 7.18 (1.98) 28; 8.04 (1.92)
iGHS 43; 7.67 (2.02) 36; 8.14 (1.66)
To what extent do you think the treatment was helpful to you?
Total sample 76; 6.86 (2.21) 64; 7.36 (1.99)
iG 33; 6.76 (2.12) 28; 7.46 (2.03)
iGHS 43; 6.93 (2.31) 36; 7.28 (1.98)
Note: Scale ranging from 0 to 10 with higher scores indicating greater satisfaction.
Abbreviations: SD, standard deviation; iG, intervention group; iGHS, intervention 
group with human support. 
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both the intervention groups, there was a significant reduc-
tion in the depression symptoms, compared with the control 
group. The improvements were maintained at follow-up in 
both the groups, and no statistically significant differences 
were found. However, in their study, the therapist support 
was through email, and there was no ICT-based automated 
support. Our data provide information about this new and 
necessary topic, showing the possibilities and potential of 
automated support in reducing the cost of treatment.
It should be noted that the literature suggests that more 
support is better, but authors understand “support” to occur 
only through human contact, and different ICT-based auto-
mated strategies for providing support are usually not con-
sidered. However, in this study, all the participants received 
automated mobile phone messages, automated emails, and 
continued automated feedback from the program.
To the best of our knowledge, only one study differen-
tiates between automated and human support in an RCT 
about an Internet-based intervention for depression.63 The 
authors concluded that an automated-support web-based 
intervention for the treatment of depression with persuasive 
technology may achieve similar adherence and effectiveness 
as the same intervention with human support.63 However, in 
order to draw more definitive conclusions about differences 
between the two intervention groups, they would need more 
statistical power, as in the present study. Nevertheless, it is 
important to highlight that in both the studies, the results are 
similar: large differences were not found between the two 
intervention conditions. Our data, as in the Kelders et al’s 
study,63 suggest that the automated support was useful. 
The participants in both the intervention groups improved 
significantly pre- to posttreatment, and this did not occur 
in the WL group.
In addition, there were no significant differences in 
adherence between the two conditions (automated and 
human support), like in an earlier study by Kelders et al.63 
A possible explanation for the lack of differences in effec-
tiveness and adherence between the two intervention groups 
can be found in the richness and quality of the ICT support. 
First, the two weekly feedback mobile messages were imple-
mented to closely resemble human feedback support. They 
encouraged the participants to proceed with the program 
and reminded them of the importance of doing the tasks 
in each module and the Activity report every day. The fact 
that there were several different alternating messages sent 
and that the length and presentation of the messages were 
similar to feedback from a person further increased their 
resemblance to human support, agreeing with Kelders et al.63 
Second, participants received an automated email encour-
aging them to continue with the modules if they had not 
accessed the program for a week, which could increase 
adherence. Third, and quite important, the program offers 
continued personalized feedback to users through various 
transversal tools for providing support as described earlier 
(Activity report, Calendar, and How am I?).
Regarding the expectations and satisfaction expressed by 
the two intervention groups, the participants reported positive 
expectations about the program. Furthermore, participants 
in both the groups reported feeling very satisfied with the 
treatment, and they found it very logical and useful, even 
for other psychological problems. In addition, they would 
recommend it to a friend, regardless of whether the support 
had been human or through ICTs, which is important because 
Internet-based interventions are easier to implement and, 
therefore, may reach more people in need. It is essential to 
continue to study other ICT strategies for providing support, 
which could further improve users’ opinions.
Furthermore, it is possible that not all participants require 
the same amount (or the same kind) of support, and this assis-
tance may only be needed at critical times during the treat-
ment program.64,65 Considering ICTs’ numerous possibilities, 
it is important to continue to study these aspects. Automated 
support through ICTs may also have significant benefits and 
influence the results, performing a similar function to human 
support (in our study, the weekly support call, so that the call 
would not be necessary), and saving even more therapist time. 
The literature shows that Internet-based, self-applied treat-
ments save therapist time compared with traditional, face-
to-face treatments.26 Therefore, it is possible that by using 
different ICT-based strategies to provide support, therapist 
time can be further reduced. This represents progress along 
the lines of Kazdin and Blase’s16 and Emmelkamp et al’s66 
proposal: psychotherapy research needs to develop interven-
tions that can be applied to more patients in a simpler and 
more cost-effective way.
Another objective of our study was to test whether the 
changes obtained at posttreatment remained until the 12-month 
follow-up. Regarding the primary outcome measure (BDI-II), 
the ITT and completer analyses revealed that the significant 
improvements obtained in both the intervention groups at 
posttreatment were maintained until the 12-month follow-up. 
A medium effect size on the BDI-II in both the intervention 
conditions was obtained by using the ITT analysis. However, a 
large effect size was obtained by using the completer analysis 
in the group with human support. These results agree with 
the Kelders et al63 study, although they present data only until 
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the 6-month follow-up. Regarding other clinical measures, 
in the ITT analysis, the participants improved significantly 
pre- to posttreatment on all measures, and the improvements 
were maintained until the 12-month follow-up, with the 
exception of PANAS-. The completer analysis revealed the 
same pattern. These findings add data to the literature on the 
maintenance of effects achieved by self-administered psy-
chological treatments delivered over the Internet.26,34,67 In this 
study, the results showed that participants who received only 
ICT-based automated support maintained their improvements 
up to the 12-month follow-up. As Richards and Richardson23 
pointed out in their meta-analysis, it is important to note the 
differences obtained between posttreatment and follow-ups 
in the case of self-applied treatments, as this evolution may 
suggest that the benefits of computerized interventions are 
more short-term. Thus, these authors emphasize the need for 
further research about maintaining the benefits of Internet-
based treatments, and the results contribute by providing 
additional data on maintaining the improvements achieved 
through these types of intervention programs without any 
human support. Nevertheless, more research is needed to 
determine whether reminders could help to prevent relapses 
and maintain the progress made in self-applied interventions, 
specifically by using ICT-based support that can be perceived 
by participants as similar to human support (avatars, mes-
sages, images, etc). For example, studies could consider 
whether receiving automatic weekly emails during follow-up 
periods would enable participants to practice the strategies 
learned during the treatment program.65
Furthermore, more research is needed regarding who is 
providing the support. In the present study, the support was 
provided by a clinician. However, as the telephone call was 
without clinical content, it would be interesting in future 
studies to study the efficacy if the support was delivered by 
technicians or non-clinicians. The studies are in the line that 
it is not important who is providing the support (researcher, 
technical or clinical).18,23,68,69
This study has some limitations. First, there was no 
enough statistical power to study the real differences between 
the two intervention groups because an equivalence or non-
inferiority trial was not performed. Therefore, it cannot 
be stated with certainty that automated support provided 
by ICTs and human support are equivalent in terms of 
effectiveness and adherence. However, although it was not 
the main goal, the study was able to explore the trend of 
the results. In the future, we intend to replicate this study 
in an adequately powered sample in order to adequately 
test the non-inferiority hypothesis (whether there are 
differences between the two active conditions). The study 
and intervention program focused on improving depressive 
symptomatology, although in the sample there were par-
ticipants with a clinical diagnosis. It would have also been 
interesting to specifically assess those participants who met 
the criteria for an adjustment disorder because all of them 
were going through a stressful event (the diagnostic interview 
used, MINI, does not include this disorder). 
Conclusion
Despite limitations, the Internet-based program was effec-
tive and well accepted, with and without human support, 
showing that ICT-based automated support may be useful. 
It is essential to continue to study other ICT strategies for 
providing support.
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Figure S1 Home module, which explains what the program is about.
Supplementary materials
Human support: specific content of weekly phone call (maximum 2 min)
The content of the phone call changed depending on the progress:
1. If the participant has not finished the module (encourage him/her to do so).
2. If the participant has finished one module in 1 week (reinforce).
3. If the participant finishes two modules in 1 week (reinforce and recommend slowing down).
4. If the participant finishes more than two modules in 1 week (recommend slowing down).
phone call structure:
a) Say hello and ask about potential problems using the system.
b) 1 (recommend doing it), 2 (reinforce), 3 (reinforce and recommend slowing down), or 4 (recommend slowing down).
1. (recommend doing it): Carry on; remember that although you can do the program at your own pace, you will benefit from it more if you do one 
module per week.
2. (reinforce): Great! You are going at a great pace, that is the idea, one module per week. remember that it is very important to do the tasks that 
the program proposes.
3. (reinforce and recommend slowing down): Good, you have finished another module, although you are going a bit too fast. Do not move forward 
and check on the tasks the program has assigned. remember that the best way is to do one module per week.
4. (recommend slowing down): You are going too fast. remember that for the strategies the program proposes to become skills, it is very 
important for you to perform the tasks and practice a lot, but it is much better if you finish just one module every week.
c) Remind them to fill out the activity report.
d) remind them to do the activities.
ICT support: specific content of the text messages
Two generic text messages (SMS) per week: on Sundays and Wednesdays.
Content of the generic text messages:
opening message:
Hello. as part of the study, you will receive two text messages a week while you are taking part in the study, at no charge to you.
Sunday:
Hello. It is very important to fill out your activity report. Remember that “what you know about yourself can help you”.
Hello. Remember to fill out your activity report. “What you know about yourself can help you”.
Hello. Please, do not forget to fill out your activity report this week. It will provide you with very valuable information.
Hello. Please, try to access the activity report every day and fill it in. Remember that “what you know about yourself can help you”.
Wednesday:
Hello. It is very important to perform the tasks in each module. “Practice is a must”. Remember that it would be great to finish one module per 
week.
Hello. Think about performing the tasks for each module. “Practice is a must”. Remember, it would be great to finish one module per week.
Hello. please, squeeze all the tasks out of the modules. You should put into practice what you learn every week.
Hello. Keep going with the tasks in each module. Dedicate some time and effort to doing them. Remember that it would be great to finish one 
module per week.
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Types of support in an internet-based intervention
Figure S2 activity report, where the participants indicate their coping ability, mood state, stress, and what percentage of the day they have been active.
Figure S3 Calendar, which shows a check mark the days the participant has done the activity report and reminds the participants the tasks that are still outstanding.
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Figure S4 How am i? The part in which the patients can see the relationship between their mood state (yellow line) and the level of their activity (green bars).
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Figure S5 Look over the modules. The participants can come back to this page and look over the finished modules.
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